Search

everythinglearnresearchcommunity

for

Search:↓

Healthcare workers with COVID-19 reported more long-term symptoms, and physical activity may help reduce some of these symptoms.

People with late-stage HIV-1 often experience a specific type of hair loss linked to multiple factors, including nutritional issues and immune responses.

Phototrichogram and hair diameter measurements are effective, noninvasive ways to assess hair growth and detect early hair loss, with the most common pattern being reduced hair density.

Common types of non-scarring hair loss have various causes and treatments, but more effective solutions are needed.

Low ferritin levels are linked to increased hair loss; no link found between vitamin B12, TSH levels, and hair loss.

COVID-19 may cause hair loss months after infection.

A woman survived a massive lithium overdose that caused a form of hair loss.

The supplement improved hair growth and reduced hair loss in women.

The treatment plan effectively improves hair growth in androgenetic alopecia.

Telogen effluvium is a hair loss condition with acute cases resolving quickly and chronic cases potentially lasting longer, sometimes requiring treatment.

Crash dieting can cause hair loss due to severe calorie restriction.

Stopping azathioprine improved hair loss and bone marrow issues.

COVID-19 may cause hair loss, often after recovery, with androgenetic alopecia being the most common type.

Telogen effluvium is a common, temporary hair loss condition often affecting young women.

Monocytes might be linked to hair loss after COVID-19.

COVID-19 and related stress may increase hair loss known as Telogen effluvium.

Menopause causes skin and hair to become drier and thinner, but hormone therapy can improve these conditions.

People with hair loss conditions often have more mental health issues like depression and anxiety compared to those without hair loss.

COVID-19 can cause different types of hair loss, which may last up to 100 days, and treatments are still being explored.

RV3466F lotion significantly reduces hair loss and improves acute telogen effluvium.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

COVID-19 infection can significantly cause temporary hair loss.

Hair loss from Telogen Effluvium can be managed by treating the underlying cause and may improve with treatments like minoxidil.

Long-haul COVID can cause lasting symptoms affecting many body systems and may be linked to ongoing inflammation and immune system issues.

Alopecia areata in children is caused by the immune system attacking hair follicles due to genetic factors.

Minoxidil and finasteride can slow hair loss and stimulate regrowth, but won't restore all lost hair or reverse complete baldness.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

COVID-19 infection may cause significant hair loss, but full hair recovery is likely without special treatment.

Photobiomodulation therapy helps manage cancer treatment side effects but needs more research for optimization.

ILC1-like cells can independently cause alopecia areata.